HIGH-ALTITUDE PULMONARY-EDEMA IS CAUSED BY STRESS FAILURE OF PULMONARY CAPILLARIES

被引:52
|
作者
WEST, JB [1 ]
MATHIEUCOSTELLO, O [1 ]
机构
[1] UNIV CALIF SAN DIEGO, DEPT MED 0623, 9500 GILMAN DR, LA JOLLA, CA 92093 USA
关键词
HYPOXIA; PULMONARY CIRCULATION; RABBIT; HIGH PERMEABILITY EDEMA; INFLAMMATORY MARKERS; VASOCONSTRICTION;
D O I
10.1055/s-2007-1024594
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
The pathogenesis of high altitude pulmonary edema (HAPE) is disputed. We propose that the mechanism is stress failure of pulmonary capillaries. The main features to be accounted for are the strong association with pulmonary hypertension, the high permeability characteristics of the edema, and the presence of inflammatory markers in the lung lavage fluid. When the capillary pressure is raised to about 40 mmHg in anesthetized rabbits, ultrastructural damage to the capillary walls is seen including breaks in the capillary endothelial layer, alveolar epithelial layer, and sometimes all layers of the wall. This results in a high permeability form of edema with the escape of high molecular weight proteins and blood cells into the alveolar spaces. In addition the basement membrane of the endothelial layer is frequently exposed, and we suggest that this highly reactive surface attracts and activates platelets and neutrophils. The result is the formation of small thrombi which are frequently seen in HAPE, and the presence of inflammatory markers such as leukotriene B4 and the complement fragment C5a in the lung lavage fluid. Hypoxic pulmonary vasoconstriction raises the pressure in some capillaries because the constriction is uneven. Since HAPE has its origin in the high pulmonary artery pressure, the objective of treatment should be to reduce the pressure by descent, administering oxygen, or giving drugs such as calcium channel blockers (e.g. nifedipine) which relax pulmonary vasoconstriction. Stress failure of pulmonary capillaries satisfactorily accounts for the features of HAPE.
引用
收藏
页码:S54 / S58
页数:5
相关论文
共 50 条
  • [41] NALOXONE, BETA ENDORPHINS, AND HIGH-ALTITUDE PULMONARY-EDEMA
    BAROR, D
    MARX, JA
    GOOD, JT
    ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) : 684 - 685
  • [42] HIGH-ALTITUDE PULMONARY-EDEMA - STILL A PLACE FOR CONTROVERSY
    RICHALET, JP
    THORAX, 1995, 50 (09) : 923 - 929
  • [43] HIGH-ALTITUDE PULMONARY-EDEMA - WHO GETS IT AND WHY
    PEACOCK, AJ
    EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (11) : 1819 - 1821
  • [44] ABNORMAL CONTROL OF VENTILATION IN HIGH-ALTITUDE PULMONARY-EDEMA
    HACKETT, PH
    ROACH, RC
    SCHOENE, RB
    HARRISON, GL
    MILLS, WJ
    JOURNAL OF APPLIED PHYSIOLOGY, 1988, 64 (03) : 1268 - 1272
  • [45] ENHANCED FIBRIN FORMATION IN HIGH-ALTITUDE PULMONARY-EDEMA
    BARTSCH, P
    WABER, U
    HAEBERLI, A
    MAGGIORINI, M
    KRIEMLER, S
    OELZ, O
    STRAUB, WP
    JOURNAL OF APPLIED PHYSIOLOGY, 1987, 63 (02) : 752 - 757
  • [46] EVALUATION OF THERAPEUTIC METHODS IN HIGH-ALTITUDE PULMONARY-EDEMA
    MARTICORENA, E
    HULTGREN, HN
    AMERICAN JOURNAL OF CARDIOLOGY, 1979, 43 (02): : 307 - 312
  • [47] RECURRENT HIGH-ALTITUDE PULMONARY-EDEMA WITH BLUNTED CHEMOSENSITIVITY
    LAKSHMINARAYAN, S
    PIERSON, DJ
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1975, 111 (06): : 869 - 872
  • [48] EIGENVALUES OF PERMEABILITY COEFFICIENTS IN HIGH-ALTITUDE PULMONARY-EDEMA
    UEDA, G
    SAKAI, A
    KOBAYASHI, T
    KUBO, K
    FUKUSHIMA, M
    YOSHIMURA, K
    SHIBAMOTO, T
    INTERNATIONAL JOURNAL OF BIOMETEOROLOGY, 1985, 29 (04) : 362 - 363
  • [49] POSITIVE AIRWAY PRESSURE FOR HIGH-ALTITUDE PULMONARY-EDEMA
    LARSON, EB
    LANCET, 1985, 1 (8425): : 371 - 373
  • [50] HIGH-ALTITUDE PULMONARY-EDEMA - PATHOPHYSIOLOGY AND CLINICAL REVIEW
    SCHOENE, RB
    ANNALS OF EMERGENCY MEDICINE, 1987, 16 (09) : 987 - 992